rss
J Clin Pathol 2004;57:938-942 doi:10.1136/jcp.2004.017814
  • Original article

Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients’ survival

  1. N P Zauber1,
  2. C Wang2,
  3. P S Lee3,
  4. T C Redondo4,
  5. D T Bishop6,
  6. A Goel5
  1. 1Department of Medicine, Saint Barnabas Medical Center, Livingston, NJ 07039, USA
  2. 2Department of Pathology, Saint Barnabas Medical Center
  3. 3Department of Pathology, Saint Barnabas Medical Center
  4. 4Department of Pathology, Saint Barnabas Medical Center
  5. 5Department of Medicine, Saint Barnabas Medical Center
  6. 6Genetic Epidemiology Division, Cancer Research UK Clinical Centre in Leeds, St James’s University Hospital, Leeds LS9 7TF, UK
  1. Correspondence to:
 Dr N P Zauber
 Department of Medicine, Saint Barnabas Medical Center, Livingston, NJ 07039, USA; pzauberaol.com
  • Accepted 19 April 2004

Abstract

Aims: The primary aim of this study was to look for possible correlations between molecular genetic changes in primary colorectal cancer and the presence or absence of micrometastases in the accompanying pericolonic lymph nodes. The secondary aim was to correlate the data on these molecular genetic changes and micrometastases with survival.

Methods: One hundred and twenty five Dukes’s stage B colorectal cancers from 1989 to 1992 were analysed. The primary tumours were evaluated for Ki-ras mutation, adenomatous polyposis coli (APC) loss of heterozygosity (LOH), deleted in colon cancer (DCC) LOH, and microsatellite instability using standard molecular techniques. All available lymph nodes were immunohistochemically stained for micrometastases.

Results: Micrometastases were present in 41% of patients. There were significantly more lymph nodes removed in the patients with micrometastases. Micrometastases were not associated with Ki-ras mutation, APC LOH, DCC LOH, or microsatellite instability, even when controlling for the number of lymph nodes removed. None of the molecular variables considered had a significant impact on either overall survival or on death with disease.

Conclusions: There are insufficient data to justify using molecular genetic changes in primary colorectal carcinomas as prognostic markers. Micrometastases do not provide prognostic information on survival. There is value in increasing the numbers of lymph nodes removed and analysed along with the primary tumour.

Footnotes

    Latest from JCP Education

    Latest from JCP Education

    Register for free content


    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
    View free sample issue >>

    Free archive
    The full back archive is now available for JCP. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • Latest Pathology jobs

    Latest Pathology jobs